Voisin Consulting Life Sciences webinar icon

Ask the Experts: How to use microbiome as an innovative diagnostic tool

Post thumbnail Ask the Experts: How to use microbiome as an innovative diagnostic tool

Over the past decade, innovations in both sequencing technology and computational biology have led to a growing interest in profiling human microbiota for therapeutic and diagnostic applications.

Recent research has highlighted how human microbiome is increasingly demonstrated as a central component of personalized medicine. Beyond well known the inter-individual variability, microbiome could represent a modifiable feature to be addressed in personalized treatment.

While most of the research remain in their early stages, specific microbial signature has already been associated with cancer promotion, inflammatory bowel disease, neurodegenerative, skin or gynecological conditions. Emergence of applications in the diagnostic area is anticipated to bring high value as innovative biomarkers for many critical conditions.

In this Ask the Expert session, we answered questions concerning topics such as:

  • Under what regulatory environment would microbiome-based diagnostics fall?
  • What are the best approaches & practices to ensure performance of testing in clinical labs regarding the new genomic technologies and microbial sequence data analysis?
  • What important methodological considerations must be anticipated for microbiome diagnostic?

Download: Answers to the key questions

Voisin Consulting Life Sciences download icon

Access the full webinar replay now

Fill in the form to download the content

    Yes, I would like to receive communications regarding VCLS services and events

    Sample of the webinar

    Featured Speakers

    Arnaud Beurdeley, M.Sc. thumbnail
    Arnaud Beurdeley, M.Sc.
    Senior Regulatory Scientist
    Arnaud is an accomplished HealthTech professional in the field of nonclinical and early clinical development with a strong expertise in microbiome-based products. He has more than 20 years of experience in translational research and molecular biology in Europe and the US. Throughout his extensive tenure in the industry, Arnaud has also successfully led multiple nonclinical development programs of in vitro diagnostic products in the field of women health and onco-immunology.
    Anne-Charlotte Jarrige, Ph.D. thumbnail
    Anne-Charlotte Jarrige, Ph.D.
    Senior Regulatory Scientist
    Anne-Charlotte has more than 20 years of experience in both consulting and pharmaceutical industries, involved in the development of in vitro diagnostic tests (including Companion Diagnostics (CDx)) in the field of Alzheimer’s disease & oncology. Her expertise encompasses navigating the complexities of regulatory requirements and managing clinical studies as well as the constitution and maintenance of regulatory dossier.